No Data
No Data
Even After Rising 29% This Past Week, Seres Therapeutics (NASDAQ:MCRB) Shareholders Are Still Down 84% Over the Past Three Years
Great Week for Seres Therapeutics, Inc. (NASDAQ:MCRB) Institutional Investors After Losing 69% Over the Previous Year
Key Insights Significantly high institutional ownership implies Seres Therapeutics' stock price is sensitive to their trading actions A total of 8 investors have a majority stake in the company
Market Chatter: Huawei Sells Interests in Aito to Seres Group
Telecommunications giant Huawei offloaded its stake in co-developed electric car brand Aito to partner Seres Group (SHA:601127) in a bid to underline its commitment to stay out of car manufacturing, Y
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity Under Strategic Partnership With Pfizer
Flagship Pioneering and ProFound Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a...
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSeres Therapeutics (NASDAQ:MCRB) stock moved upwards by 34.0% to $0.82 during Monday's regular session. The company's market cap stands at $124.5 million. Renovaro (NASDAQ:RENB) shares increase
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of GameStop Corp. (NYSE:GME) fell sharply during Friday's session after the company released worse-than-expected first-quarter results before schedule and filed to sell up to 75 million shares.
No Data